AKT1 and hepatocellular carcinoma: Notably, PIK3CB mutations have been linked to early-stage HCC recurrence, while PTEN loss has been observed in up to 53% of HCC tumors, resulting in uncontrolled PI3K/AKT activation [29,30,31].